189 related articles for article (PubMed ID: 171534)
1. Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.
Rotrosen J; Friedman E; Gershon S
Life Sci; 1975 Aug; 17(4):563-8. PubMed ID: 171534
[No Abstract] [Full Text] [Related]
2. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
[TBL] [Abstract][Full Text] [Related]
3. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
Nakahara T; Uchimura H; Saito M; Hirano M; Kim JS; Ito M
J Neurochem; 1978 Nov; 31(5):1335-7. PubMed ID: 702178
[No Abstract] [Full Text] [Related]
5. Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).
Miller RJ; Iversen LL
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):213-6. PubMed ID: 4369214
[No Abstract] [Full Text] [Related]
6. Decreased spontaneous motor activity parallels reserpine-induced supersensitivity of catecholamine-responsive rat cerebral cortex adenylate cyclase.
Wagner HR; Palmer GC; Hall TL; Putnam RW
Behav Biol; 1978 Jun; 23(2):225-9. PubMed ID: 678261
[No Abstract] [Full Text] [Related]
7. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
Miller R; Horn A; Iversen L; Pinder R
Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
[No Abstract] [Full Text] [Related]
8. Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine.
Kaneno S; Watanabe S; Toru M; Shimazono Y
Brain Res; 1978 Aug; 152(2):396-400. PubMed ID: 679034
[No Abstract] [Full Text] [Related]
9. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
Roufogalis BD; Thornton M; Wade DN
Life Sci; 1976 Sep; 19(6):927-34. PubMed ID: 966971
[No Abstract] [Full Text] [Related]
10. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
[TBL] [Abstract][Full Text] [Related]
11. Neurohumoral regulation of adenylate cyclase activity in rat striatum.
Walker JB; Walker JP
Brain Res; 1973 May; 54():386-90. PubMed ID: 4145382
[No Abstract] [Full Text] [Related]
12. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
13. Localization of dopamine receptors in the rat cerebral cortex.
Trabucchi M; Govoni S; Tonon GC; Spano PF
J Pharm Pharmacol; 1976 Mar; 28(3):244-5. PubMed ID: 6700
[No Abstract] [Full Text] [Related]
14. LSD as an agonist and antagonist at central dopamine receptors.
Von Hungen K; Roberts S; Hill DF
Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
[No Abstract] [Full Text] [Related]
15. Effects of bromocriptine on central dopaminergic receptors.
Trabucchi M; Spano PF; Tonon GC; Frattola L
Life Sci; 1976 Jul; 19(2):225-31. PubMed ID: 183071
[No Abstract] [Full Text] [Related]
16. Monoamine activation and enkephalin inhibition of adenylate cyclase in dorsal and ventral striatum of the rabbit.
Christie-Pope BC; Palmer GC; Chronister RB
Neuropharmacology; 1984 Jul; 23(7A):763-72. PubMed ID: 6472580
[TBL] [Abstract][Full Text] [Related]
17. Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain.
Trabucchi M; Longoni R; Fresia P; Spano PF
Life Sci; 1975 Nov; 17(10):1551-6. PubMed ID: 173950
[No Abstract] [Full Text] [Related]
18. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
Marshall AM; Ramwani J; Mishra RK
Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
[TBL] [Abstract][Full Text] [Related]
19. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
Seeber U; Kuschinsky K
Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
[TBL] [Abstract][Full Text] [Related]
20. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.
Puri SK; Cochin J; Volicer L
Life Sci; 1975 Mar; 16(5):759-67. PubMed ID: 164598
[No Abstract] [Full Text] [Related]
[Next] [New Search]